Abstract Neurons and glia are highly susceptible to reactive oxygen species that play a key role in various neurodegenerative diseases. Menadione, a synthetic derivative of vitamin K, induces reactive oxygen generation. Quercetin one of the most ubiquitous bioflavonoids in food of plant origin, has strong antioxidant activities on different cell types, however recent studies demonstrated that it has also prooxidant and cytotoxic potentials. We examined the action of pre-and co-treatment of quercetin on menadione induced glial toxicity. The primary mixed glial cells obtained from 1 to 3 day old rat brain were pretreated with 10, 25, 100 or 250 lM quercetin for 1 h, washed out and 10, 25, 50, 75 or 100 lM menadione was added for 6 h. The other group of cells was treated with respective doses of quercetin combined simultaneously with the same doses of menadione for 6 h. The cells were washed and incubated for additional 24 h for recovery period and the viability was measured by using MTT assay. Menadione was dose-dependently toxic to glia cells and pretreatment with respective quercetin doses for 1 h could not eliminate this toxicity. Although 10 and 25 lM quercetin combined with 10 and 25 lM menadione could not change, 100 and 250 lM quercetin together with 10 or 25 lM menadione for 6 h increased further the menadione induced toxicity. We conclude that when combined with menadione, quercetin at high doses could be toxic to primary rat glia cells in culture.
Introduction
The brain is particularly vulnerable to oxidative damage as a result of its high oxygen consumption rate. It utilizes 20% of the total oxygen consumed though it comprises only 2% of the body weight (Gitika et al. 2006) . The membrane lipids in the brain are rich in polyunsaturated fatty acid side chains which are especially sensitive to free radical attacks (Cafe et al. 1995; Leuther et al. 2001) . Oxidative stress leads to enhance production of reactive oxygen species (ROS), which can modify DNA, proteins, lipids and carbohydrates in cells resulting in various neurological disorders such as trauma, ischemia, Alzheimer's and Parkinson's diseases (Floyd 1999) . Therefore, a large number of studies focus on oxidative damage as a common mechanism of neurotoxicity.
Acute cardiac and renal toxicity of menadione, a synthetic derivative of vitamin K, in rat at 25, 50, 100 and 150 mg/kg were reported with a dose-response relationship (Chiou et al. 1997) however, 1 mM menadione killed all cultured rat cortical astrocytes in 6 h (Abe and Saito 1996) and as low as 10 lM menadione decreased viability of bovine aortic endothelial cells in 8 h (Takahashi et al. 2009 ). Menadione is a strong oxidizing agent that can generate a great quantity of ROS when it enters cells (Lamson and Plaza 2003) . The cytotoxic effect of menadione is thought to be mediated through its one or two electron reduction to semiquinone or hydroquinone radicals, which subsequently enter redox cycle with molecular oxygen to produce ROS and oxidative stress (Ngo et al. 1999) . Because of these reasons, menadione has been widely used as an oxidant to study oxidative stress in mammalian systems (Lee et al. 2001) .
Quercetin belongs to a group of plant pigments called flavonoids and is a convenient compound of major human dietary constituents of vegetables, tea, fruit and wine (Lamson and Brignall 2000) . Quercetin is generally considered to have strong antioxidant potency and provides protection against oxidative injury in cultured cells (Boots et al. 2007 ). The antioxidant properties of quercetin might be via an ability to chelate transition metal ions, such as iron and copper, catalyze electron transport and scavenge ROS (Choi et al. 2003) . Pretreatment of quercetin protects against hydrogen peroxide (Saito et al. 2004) , glucose oxidase and menadione (Aherne and O'Brien 2000; Park et al. 2003) induced toxicity in different cell types. It was reported that both pre-and co-treatment of quercetin with different exitotoxins showed a neuroprotective activity on mouse primary cortical culture (Ha et al. 2003) . Although the multiple activities of quercetin were believed to be due to its strong antioxidant properties (Lee et al. 2001) , recent studies indicated that it has prooxidant and cytotoxic effects on different cell types (Matsuo et al. 2005) . The dose levels of quercetin in long term animal studies suggest the addition of 200-500 mg/day quercetin to diet without any toxic effect (Harwood et al. 2007 ) however, the concentration at which cultured cell growth was inhibited by IC 50 ranged from 7 nM (Lamson and Brignall 2000) to 303 lM (Matsuo et al. 2005) . In light of these findings, we postulated to examine first time whether pre-treatment and cotreatment of quercetin can prevent menadione induced toxicity in rat primary glial cells in vitro.
Materials and methods
All the reagents were obtained from Sigma and the glial cells from whole brains of 1-3 day old SpraqueDawley rats as described previously (Lopez et al. 2007) . Briefly, the cells collected from 4 rats were combined and then cultured in a humidified atmosphere of 5% CO 2 , at 37°C in 25 cm 2 flasks. The culture medium consisted of Dulbecco's Modified Eagle's Medium (DMEM), 10% fetal bovine serum (FBS) and 1% penicilin-streptomycine solution. The cells were determined as glia by using glial fibrillary acidic protein antibody by immunohistochemical staining. When confluence was achieved, primary glial cells were dissociated with trypsinization and centrifuged at 1,000 rpm, 4°C for 5 min. The supernatant was discarded and the samples were counted with a Coulter counter. The glial cells were seeded in 96 well plates (2 9 10 4 cells/well) for 24 h in 8 wells for the control and 8 wells for each tested drug dose. To minimize the protective effect of FBS on the quercetin action, FBS ratio in culture medium was adjusted for 1% (Rouzaire-Dubois et al. 1993) . Menadione (menadione sodium bisulfate) was dissolved in DMEM. Quercetin was dissolved in dimethylsulfoxide (DMSO) and diluted in DMEM to the highest concentration of 0.01% (v/v). All test compounds were prepared immediately prior to use and protected from light.
Experimental groups:
Control group: Culture medium. Menadione group: Treated with 10, 25, 50, 75 or 100 lM menadione for 6 h. Quercetin group: Treated with 10, 25, 100 or 250 lM quercetin for 6 h. Pretreatment group: Pretreated with respective quercetin doses for 1 h and then respective menadione doses were added for 6 h. Combination group: Respective doses of quercetin and menadione were applied simultaneously for 6 h.
After 6 h cells were washed, fed with fresh medium for 24 h and then viability was measured by colorimetric assay with 3-(4,5 dimethylthiazol2yl)-2,5-diphenyl tetrazolium bromide (MTT, Mossmann 1983) . The optical density read at 550 nm from the drug treated wells was converted to a percentage of living cells against the control using the following formula: Absorbance of treated cells in each well 9 100/the mean absorbance of control cells. Data were expressed as the mean percent fraction of control ± standard error of mean (SEM). Statistical significance was ascertained by one way analysis of variance, followed by Tukey's multiple comparison tests. The results are means of at least three independent assays and a p value less than 0.05 was considered to be significant.
Results
The highest concentration of DMSO or the treatment of primary glial cells with respective concentrations of quercetin alone for 6 h did not change the cell viability rate (data not shown).
When compared to the control, 10 lM menadione applied alone for 6 h decreased the cell viability by about 22% (Fig. 1) . The pretreatment of glia with respective quercetin doses could not eliminate this 10 lM menadione caused toxicity. The combination of 10 lM menadione with either 10 or 25 lM quercetin did also not change significantly the menadione toxicity, however 100 and 250 lM quercetin increased this toxicity further by about 21 and 31% more, respectively.
After exposure of glial cells to 25 lM menadione alone for 6 h, cell viability was calculated to be 34% lower than the control (Fig. 2) . Pretreatment of the cells with respective quercetin doses could not again eliminate 25 lM menadione caused toxicity. Either 10 or 25 lM quercetin combined simultaneously with 25 lM menadione could not affect, but 100 and 250 lM quercetin decreased further cell viability about 27 and 31% more, respectively.
As shown in Fig. 3 , alone 50 lM menadione reduced the cell viability by about 61%. Although the combination of respective quercetin doses with 50 lM menadione decreased the glia viability, data were not statistically significant. Pretreatment of respective quercetin doses with 50 lM menadione caused some unsignificant changes in the cell viability.
Since 75 and 100 lM menadione doses induced almost the same toxic ratio, 100 lM menadione induced toxicity is not shown. Since 75 lM menadione killed almost 71% of the cells within 6 h, we believe that there was not left enough number of cells to be influenced by either combination or pretreatment with respective doses of quercetin (Fig. 4) .
Discussion
The present study was designed to determine effects of pretreatment and combined treatment of quercetin on menadione induced toxicity on primary rat glial cells. We preferred menadione because of the major mediator of oxidative stress and usually chosen as a suitable source of ROS for the study of their biological role (Lee et al. 2001) . We found that quercetin alone at respective doses was not able to alter the number of living glial cells in 6 h. Jagadeeswaran et al. (2000) demonstrated that 10-40 lg/ml quercetin did not affect cell viability, morphological changes and lactate dehydrogenase activity of African green monkey kidney cells in 48 h. Likewise, 200 lM quercetin did not change cell viability in 24 h for both human colonic adenocarcinoma cells (Caco-2) and human hepatocellular carcinoma cells HepG2 (Aherne and O'Brien 1999) . In another study, concentrations of quercetin less than 100 lM were not toxic, but higher than 100 lM was highly cytotoxic by accelerating the generation of H 2 O 2 and superoxide in human lymphocytes in 30 min (Yen et al. 2003) . It was also reported that 100 lM or more quercetin reduced the cell viability of rat aortic smooth muscle cells (Shih et al. 2004) and mouse neuroblastoma 9 glioma hybrid cells in a concentration dependent manner in 48 h (RouzaireDubois et al. 1993) . Depending on dose and free radical source, quercetin induced hydrogen peroxide and super oxide anion in human lung embryonic fibroblast and human umbilical vein endothelial cultured cells in 24 h (Matsuo et al. 2005) . Thus, quercetin can exert different effects (anti-/prooxidant) depending on concentration, exposure time, cell type and oxidative balance.
Pretreatment of the cells with respective quercetin doses for 1 h had no influence on menadione caused toxicity on our rat primary glial cells. The treatment time was modified from the study of Gitika et al. (2006) . Our study was first in terms of testing the effect of quercetin on menadione toxicity in primary mixed glial cells. Pretreatment of mouse thymocytes in cultures with 50 lM quercetin for 2 h inhibited glucose oxidase mediated apoptosis . Saito et al. (2004) showed that 1 h pretreatment with 1 lM quercetin prevented 20 lM H 2 O 2 induced chromosomal damage in human B lymphoblastoid cells (WIL2-NS) in 30 min. Moreover, pretreated with 50 lg/mL quercetin for 30 min and followed by treatment with 20 lM menadione for 12 h, quercetin had significantly protective capacity in H9c2 cells against oxidative stress induced by menadione in vitro . In another study, preincubation of 50 lM quercetin for 24 h protected against 10 lM menadione-induced DNA single strand breaks by acting both as metal chelator and radical scavenger in Caco-2 (Aherne and O'Brien 2000) . In contrast, Bestwick and Milne (2001) reported that preincubation with quercetin concentrations of 10 lM or more for 45 min protects against 20 lM menadione induced DNA single strand breaks, conversely exacerbate membrane damage in HL-60 cells. It seems that the effect of quercetin pretreatment may depend on the concentration of quercetin, exposure time, cell type and/or culture conditions.
Another result of our study is that simultaneous combination of menadione with higher doses of quercetin further increased menadione toxicity. We did not encounter with any published data about combined treatment of quercetin with menadione on cultured glial cells. Ha et al. (2003) reported that both pre-and co-treatment with 1-10 lM concentrations of quercetin did not have a neuroprotective effect; however concentrations of quercetin of 30-100 lM protected against neurotoxicity induced by different excitotoxins in mouse primary cortical cultures for 20 and 24 h. We have found in another study that 100 lM H 2 O 2 alone decreased the glial cell number by 75% in culture however, exposed for 3 h simultaneously with the same amount of H 2 O 2 , both 75 and 100 lM quercetin eliminated this toxic effect by 15% (unpublished data). Vafeiadou et al. (2008) demonstrated that quercetin is rapidly conjugated to glutathione (GSH) within glial cells. Depletion of GSH concentration and glutathione reductase activity via quercetin implies the weakness of antioxidant defense system and causes oxidative damage. A dysfunction of glutathione metabolites has been found to be also important in most neurodegenerative diseases (Choi et al. 2003) . In addition, menadione also decreases the GSH level significantly in human hepatocytes and fibroblasts (Morrison et al. 1985) and, 5 hepatoma cell lines and 4 different carcinoma cells (Wu et al. 1993) . Furthermore, some investigators reported that intracellular metabolic degradation of quercetin forms different reactive and cytotoxic metabolites via enzymatic or non-enzymatic pathways in various cell types (Awad et al. 2001 (Awad et al. , 2002 Boots et al. 2007) . It is possible that produced in the presence of menadione, these metabolites may play an important role on quercetin toxicity in the cells.
In conclusion, the present study indicate that while pretreatment with quercetin for 1 h had no effect against menadione toxicity, combined treatment of menadione with the higher doses of quercetin increased menadione toxicity further on primary rat glial cells in vitro.
